[ad_1]
If approved, the drug would be a fantastic new option as an alternative to insulin.
According to one study, a new treatment for type 2 diabetes in children has been shown to be promising in a clinical trial.
The drug, liraglutide, in combination with an existing drug, metformin, has shown a robust effect in treating children with type 2 diabetes, the results showed.
"This adult diabetes medication has been very effective in our trial of young people with type 2 diabetes and has been well tolerated," said Jane Lynch, co-author of the study, a professor at the Center for Disease Control and Prevention. University of Texas Health Sciences in San Antonio, United States.
Currently, only two drugs, metformin and insulin, are approved for the treatment of type 2 diabetes in children in the United States.
"We urgently need other medical treatment options for type 2 diabetes in our young people under the age of 18. If approved, this drug would be a fantastic new option to complete treatment with the Oral metformin as an alternative to insulin for our young people and adolescents with type 2 diabetes, "Lynch said.
The study compared the results of 66 children who received injections of liraglutide plus metformin tablets for 26 weeks with the results of 68 other children who received metformin and placebo. Children aged 10-17 were eligible for the study.
The research, published in the New England Journal of Medicine, was a placebo-controlled, randomized, parallel-group trial.
The average age of participating children was 14.6 years and more than 60% were female.
Indo-Asian Information Service
[ad_2]
Source link
